Evaluation of Plasma Soluble Urokinase Plasminogen Activator Receptor Levels in Patients With COVID-19 and Non-COVID-19 Pneumonia: An Observational Cohort Study.

Dimitrios Velissaris,Maria Lagadinou,Themistoklis Paraskevas,Eleousa Oikonomou,Vasileios Karamouzos,Sofia Karteri,Dimitrios Bousis,Nikolaos Pantzaris,Konstantinos Tsiotsios,Markos Marangos

Journal of clinical medicine research（2021）

引用 10|浏览3

暂无评分

摘要

A single measurement of suPAR on admission can provide prognostic information for patients with suspected COVID-19 pneumonia. In the subgroup of patients with positive real-time PCR result for SARS-CoV2, suPAR was significantly higher and had an excellent prognostic value for the in-hospital mortality.

查看译文

关键词

Biomarker,COVID-19,Chest infection,Prognosis,suPAR

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要